Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00512577
Status:
TERMINATED
Last Update Posted:
2023-03-23
First Post:
2007-08-06
Brief Title:
Transfusion Alternatives Pre-operatively in Sickle Cell Disease TAPS
Sponsor:
NHS Blood and Transplant
Organization:
NHS Blood and Transplant
Study Overview
Official Title:
Transfusion Alternatives Pre-operatively in Sickle Cell Disease
Status:
TERMINATED
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Study was terminated by Trial Steering Committee
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TAPS
Brief Summary:
TAPS is a sequential trial which aims to investigate whether the administration of a blood transfusion pre-operatively to patients with sickle cell disease HB SS or Hb SB0 thalhaving low or medium risk elective surgery increases or decreases the overall rate of peri-operative complications The proportion of patients with peri-operative complications in two randomised groups of transfused and untransfused patients will be compared
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| ISRCTN00862331 | None | None | None |